GUGGENHIME ANDREW sold PCVX
June 18, 2026 · Form 4 insider transaction
GUGGENHIME ANDREW sold 10,000 shares of Vaxcyte, Inc. at $53.00 per share, a transaction worth $530.0K. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 0 days after the transaction.
Direction
Disposed (sell-side)
Shares
10,000
Price
$53.00
Total value
$530.0K
InsiderGUGGENHIME ANDREW
Role—
CompanyVaxcyte, Inc. (PCVX)
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateJune 18, 2026
Filing dateJune 18, 2026
Shares owned after104,395
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
The sale reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted March 4, 2026.